primary_id,case_id,case_version,fda_date,age,sex,country,role_cod,drug_sequence,drug_name,active_ingredient,adverse_event,outcome,indication_sequence,indication,start_date,end_date,dur,dur_cod,exposure_days,report_recency_days,PRR,ROR,is_disproportional_signal,is_rare_pair,is_signal,probability
1001,2001,1,20250610,65,M,US,PS,1,ATORVASTATIN,ATORVASTATIN,Myalgia,HO,1.0,Hyperlipidemia,,,180.0,DY,0,0,,,,,0,0.075
1002,2002,1,20250615,34,F,US,SS,2,METFORMIN,METFORMIN,Diarrhoea,DS,1.0,Type 2 Diabetes,,,90.0,DY,0,0,0.5187223134985952,0.5171279553430983,0.0,,0,0.06
1003,2003,2,20250620,78,M,JP,SS,3,ASPIRIN,ACETYLSALICYLIC ACID,GI bleed,LT,2.0,Cardiovascular prevention,,,0.0,,0,0,,,,,1,0.63
